Target
Glutaminase liver isoform, mitochondrial
Ligand
BDBM50548670
Substrate
n/a
Meas. Tech.
ChEMBL_2022796 (CHEMBL4676609)
IC50
>50000±n/a nM
Citation
 Soth, MJLe, KDi Francesco, MEHamilton, MMLiu, GBurke, JPCarroll, CLKovacs, JJBardenhagen, JPBristow, CACardozo, MCzako, Bde Stanchina, EFeng, NGarvey, JRGay, JPDo, MKGGreer, JHan, MHarris, AHerrera, ZHuang, SGiuliani, VJiang, YJohnson, SBJohnson, TAKang, ZLeonard, PGLiu, ZMcAfoos, TMiller, MMorlacchi, PMullinax, RAPalmer, WSPang, JRogers, NRudin, CMShepard, HESpencer, NDTheroff, JWu, QXu, AYau, JADraetta, GToniatti, CHeffernan, TPJones, P Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties. J Med Chem 63:12957-12977 (2020) [PubMed]  Article 
Target
Name:
Glutaminase liver isoform, mitochondrial
Synonyms:
3.5.1.2 | GA | GLS | GLS2 | GLSL_HUMAN | Glutaminase liver isoform, mitochondrial | L-glutaminase | L-glutamine amidohydrolase
Type:
PROTEIN
Mol. Mass.:
66331.64
Organism:
Homo sapiens
Description:
ChEMBL_117753
Residue:
602
Sequence:
MRSMKALQKALSRAGSHCGRGGWGHPSRSPLLGGGVRHHLSEAAAQGRETPHSHQPQHQDHDSSESGMLSRLGDLLFYTIAEGQERIPIHKFTTALKATGLQTSDPRLRDCMSEMHRVVQESSSGGLLDRDLFRKCVSSNIVLLTQAFRKKFVIPDFEEFTGHVDRIFEDVKELTGGKVAAYIPQLAKSNPDLWGVSLCTVDGQRHSVGHTKIPFCLQSCVKPLTYAISISTLGTDYVHKFVGKEPSGLRYNKLSLNEEGIPHNPMVNAGAIVVSSLIKMDCNKAEKFDFVLQYLNKMAGNEYMGFSNATFQSEKETGDRNYAIGYYLKEKKCFPKGVDMMAALDLYFQLCSVEVTCESGSVMAATLANGGICPITGESVLSAEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSAVSGAILLVVPNVMGMMCLSPPLDKLGNSHRGTSFCQKLVSLFNFHNYDNLRHCARKLDPRREGAEIRNKTVVNLLFAAYSGDVSALRRFALSAMDMEQKDYDSRTALHVAAAEGHIEVVKFLIEACKVNPFAKDRWGNIPLDDAVQFNHLEVVKLLQDYQDSYTLSETQAEAAAEALSKENLESMV
  
Inhibitor
Name:
BDBM50548670
Synonyms:
CHEMBL4741924
Type:
Small organic molecule
Emp. Form.:
C24H27F3N8O3
Mol. Mass.:
532.5182
SMILES:
CNC(=O)c1cn(C[C@H](F)CCc2ccc(NC(=O)Cc3cc(OC4CC(F)(F)C4)cc(C)n3)nn2)nn1 |r|
Structure:
Search PDB for entries with ligand similarity: